CellaVision AB (publ)

BATS-CHIXE:CEVIS Stock Report

Market Cap: SEK 4.9b

CellaVision Past Earnings Performance

Past criteria checks 2/6

CellaVision has been growing earnings at an average annual rate of 7.7%, while the Medical Equipment industry saw earnings declining at 9.5% annually. Revenues have been growing at an average rate of 12.8% per year. CellaVision's return on equity is 14.6%, and it has net margins of 16%.

Key information

7.7%

Earnings growth rate

7.7%

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate12.8%
Return on equity14.6%
Net Margin16.0%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How CellaVision makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BATS-CHIXE:CEVIS Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 236029719691
31 Mar 236169919691
31 Dec 2263911819189
30 Sep 2265112619486
30 Jun 2264214218672
31 Mar 2259413517467
31 Dec 2156612516564
30 Sep 2153211416061
30 Jun 2148810115054
31 Mar 214719814752
31 Dec 204718915251
30 Sep 204908515954
30 Jun 204988916559
31 Mar 204929216360
31 Dec 194629915056
30 Sep 1942310413553
30 Jun 1941210413148
31 Mar 193919712443
31 Dec 183658912039
30 Sep 183307611433
30 Jun 183076710930
31 Mar 182946310627
31 Dec 173097010627
30 Sep 173067010128
30 Jun 17313789728
31 Mar 17300759230
31 Dec 16265608629
30 Sep 16254578529
30 Jun 16260668227
31 Mar 16246558228
31 Dec 15239538227
30 Sep 15250498429
30 Jun 15223308228
31 Mar 15226348325
31 Dec 14217318023
30 Sep 14209337319
30 Jun 14207367017
31 Mar 14189266718
31 Dec 13180196621
30 Sep 1316536721
30 Jun 13156-16822
31 Mar 1316326822
31 Dec 1217066821
30 Sep 12166176822

Quality Earnings: CEVIS has high quality earnings.

Growing Profit Margin: CEVIS's current net profit margins (16%) are lower than last year (22%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: CEVIS's earnings have grown by 7.7% per year over the past 5 years.

Accelerating Growth: CEVIS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: CEVIS had negative earnings growth (-31.7%) over the past year, making it difficult to compare to the Medical Equipment industry average (-12.2%).

Return on Equity

High ROE: CEVIS's Return on Equity (14.6%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/08/06 02:28
End of Day Share Price 2023/05/09 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CellaVision AB (publ) is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sten GustafssonABG Sundal Collier
Bjorn RydellABG Sundal Collier Sponsored
Carl-Oscar BredengenBerenberg